Oscar Health (NYSE:OSCR) Insider Mario Schlosser Sells 23,038 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 23,038 shares of the company’s stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total value of $406,620.70. Following the sale, the insider owned 350,180 shares of the company’s stock, valued at $6,180,677. This trade represents a 6.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Mario Schlosser also recently made the following trade(s):

• On Tuesday, January 6th, Mario Schlosser sold 76,962 shares of Oscar Health stock. The shares were sold at an average price of $17.01, for a total value of $1,309,123.62.
• On Wednesday, December 24th, Mario Schlosser sold 38,835 shares of Oscar Health stock. The stock was sold at an average price of $15.00, for a total transaction of $582,525.00.
• On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The stock was sold at an average price of $16.59, for a total transaction of $397,579.35.
• On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The shares were sold at an average price of $15.27, for a total transaction of $4,369,999.14.

Oscar Health Stock Down 0.3%

Shares of OSCR traded down $0.05 during trading hours on Monday, reaching $17.68. 8,328,260 shares of the stock traded hands, compared to its average volume of 9,028,688. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80. The company has a market cap of $4.68 billion, a price-to-earnings ratio of -15.78 and a beta of 1.90. The stock has a fifty day simple moving average of $15.80 and a 200 day simple moving average of $16.93. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. During the same quarter last year, the firm earned ($0.22) EPS. The company’s quarterly revenue was up 23.2% compared to the same quarter last year. On average, equities analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Institutional Investors Weigh In On Oscar Health

Institutional investors have recently made changes to their positions in the stock. American Century Companies Inc. grew its position in shares of Oscar Health by 89.0% in the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after purchasing an additional 2,495,691 shares in the last quarter. Farallon Capital Management LLC boosted its stake in Oscar Health by 146.5% in the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the period. Thrive Capital Management LLC grew its holdings in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares in the last quarter. State of Michigan Retirement System bought a new stake in shares of Oscar Health during the third quarter valued at about $27,448,000. Finally, Jump Financial LLC increased its position in shares of Oscar Health by 798.3% during the second quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock valued at $30,906,000 after buying an additional 1,281,032 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on OSCR shares. UBS Group upgraded Oscar Health from a “sell” rating to a “neutral” rating and upped their price objective for the company from $12.00 to $17.00 in a research note on Friday. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Wells Fargo & Company lowered their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Finally, Barclays set a $18.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a research note on Monday, January 5th. One equities research analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Oscar Health presently has an average rating of “Reduce” and an average price target of $17.00.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.